Untreated Wilson's disease in advanced stage is associated with high neurological morbidity, and effective treatment with chelating agents and zinc salts has shown to prevent the development of or reverse neurological symptoms.
Figure 1: CT scan Brain showing prominent symmetrical demyelination in subcortical white mater of frontal lobes
On examination, KF ring was still present on the superior and inferior margins of both corneae. He had spastic dysarthria, a speech characterized by echolalia and occasional outbursts of panic. Neurological examination also showed saccadic dysmetria, decreased vibratory and joint position sense in the feet, brisk tendon reflexes, extensor plantar responses, marked truncal ataxia, dystonic posturing of both hands and feet and cogwheel rigidity at the wrists. Serum ceruloplasmin 2.34 mg/dl, serum copper 16 µg/dl and serum Zinc 155 µg/dl and a normocytic normochromic anemia with anisopoikilocytosis. CT brain showed diffuse hypodensity involving white matter tracts bilaterally, attenuation in the range of 15-18Hu, consistent with demyelination, predominantly in the frontal, parietal, and temporal regions, sparing the posterior. Prominence of the bilateral lateral ventricles and the third ventricle was seen along with mild cerebral and basal ganglia atrophy region [ Figures 1 and 2 ]. Brain stem and cerebellum appeared normal. 
Discussion
At the initial diagnosis of Wilson's disease in this patient, no CNS symptoms were reported and CT brain was remarkable only for bilateral caudate nucleus atrophy and his serum ceruloplasmin then was in the low normal range, i.e. 27.5 mg/dl. But after four years of treatment with 750 mg/d penicillamine, which is equivalent to the adult maintenance dose, and 280 mg/ d of zinc, which is nearly double the adult maintenance dose, the serum ceruloplasmin was virtually undetectable and serum copper (16 µg/dl) was much lower than the normal range of 80 to 120 µg/dl. As reported by Prodan et al. [2] CNS demyelination seen in this patient is emphatically attributable to the hypocupremia. A possible mechanism for the demyelination could be hypocupremia leading to deficiency of many copper containing metalloenzymes such as superoxide dismutase (SOD), which plays a vital role in protection against oxidative damage.
[3] This case exemplifies the importance of frequent monitoring of serum copper and ceruloplasmin levels in Wilson's disease patients undergoing treatment, specially if they are in the pediatric age group, and adjustment of the dosages of the drugs accordingly, to prevent further neurological complications such as CNS demyelination [2] and myeloneuropathy [4] due to hypocupremia.
